Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoma”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07231523
What this trial is testing

EFG vs IVIG in TAMG

Who this might be right for
EfgartigimodIntravenous ImmunoglobulinMyasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital 64
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT02623127
What this trial is testing

Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Seoul National University Hospital 25
Not applicableStudy completedNCT00777751
What this trial is testing

Radiation Therapy and Cardiac Enzymes

Who this might be right for
Tumor
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03076554
What this trial is testing

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Who this might be right for
ThymomaThymic Carcinoma
National Cancer Institute (NCI) 56
Early research (Phase 1)Ended earlyNCT01258868
What this trial is testing

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Who this might be right for
MesoltheliomaEsophageal CancerLung Cancer+2 more
National Cancer Institute (NCI) 44
Not applicableActive Not RecruitingNCT05150210
What this trial is testing

SP Thoracic IDE Study

Who this might be right for
Primary Lung CancerBenign Lung DiseaseThymoma+1 more
Intuitive Surgical 32
Not applicableStudy completedNCT07179341
What this trial is testing

Survival Nomogram for Patients With Thymic Carcinoma

Who this might be right for
Thymic Carcinoma
Weijie Ye 156
Testing effectiveness (Phase 2)Ended earlyNCT01301391
What this trial is testing

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Who this might be right for
Malignant Thymoma
Tiziana Life Sciences LTD 30
Testing effectiveness (Phase 2)Study completedNCT00003283
What this trial is testing

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Who this might be right for
Thymoma and Thymic Carcinoma
Eastern Cooperative Oncology Group 38
Not applicableLooking for participantsNCT05667948
What this trial is testing

Molecular Analysis and Treatment Options of Thymic Malignancies

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymic Cancer
Shanghai Chest Hospital 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03463460
What this trial is testing

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Who this might be right for
Thymic Carcinoma
Dwight Owen 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790706
What this trial is testing

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Who this might be right for
Peritoneal MesotheliomaGestational Trophoblastic TumorAnaplastic Thyroid Carcinomas+3 more
Hospices Civils de Lyon 27
Testing effectiveness (Phase 2)Study completedNCT02307500
What this trial is testing

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

Who this might be right for
Pancreas CancerOvarian CancerMelanoma+4 more
Istituto Clinico Humanitas 82
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT07824505
What this trial is testing

Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy

Who this might be right for
Advanced Thymic Carcinoma
Haihe Biopharma Co., Ltd. 74
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT03583086
What this trial is testing

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Who this might be right for
Thymic CarcinomaNon-small Cell Lung CancerRefractory Thoracic Tumors+1 more
Vanderbilt-Ingram Cancer Center 88
Testing effectiveness (Phase 2)Looking for participantsNCT05683886
What this trial is testing

KC1036 in Patients with Advanced Thymic Tumors

Who this might be right for
Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd. 30
Large-scale testing (Phase 3)Looking for participantsNCT06402708
What this trial is testing

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Who this might be right for
Thymic Carcinoma
Fudan University 172
Next Page